| Erdafitinib in locally advanced or metastatic urothelial carcinoma Y Loriot, A Necchi, SH Park, J Garcia-Donas, R Huddart, E Burgess, ... New England Journal of Medicine 381 (4), 338-348, 2019 | 1093 | 2019 |
| Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial DP Dearnaley, MR Sydes, JD Graham, EG Aird, D Bottomley, RA Cowan, ... The lancet oncology 8 (6), 475-487, 2007 | 1071 | 2007 |
| Multiple newly identified loci associated with prostate cancer susceptibility RA Eeles, Z Kote-Jarai, GG Giles, AAA Olama, M Guy, SK Jugurnauth, ... Nature genetics 40 (3), 316-321, 2008 | 1007 | 2008 |
| Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer ND James, SA Hussain, E Hall, P Jenkins, J Tremlett, C Rawlings, ... New England Journal of Medicine 366 (16), 1477-1488, 2012 | 994 | 2012 |
| European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I S Krege, J Beyer, R Souchon, P Albers, W Albrecht, F Algaba, M Bamberg, ... European urology 53 (3), 478-496, 2008 | 764 | 2008 |
| Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array RA Eeles, AAA Olama, S Benlloch, EJ Saunders, DA Leongamornlert, ... Nature genetics 45 (4), 385-391, 2013 | 669 | 2013 |
| European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) HJ Schmoll, R Souchon, S Krege, P Albers, J Beyer, C Kollmannsberger, ... Annals of Oncology 15 (9), 1377-1399, 2004 | 661 | 2004 |
| Cardiovascular disease as a long-term complication of treatment for testicular cancer RA Huddart, A Norman, M Shahidi, A Horwich, D Coward, J Nicholls, ... Journal of Clinical Oncology 21 (8), 1513-1523, 2003 | 643 | 2003 |
| Stereotactic body radiotherapy for oligometastases AC Tree, VS Khoo, RA Eeles, M Ahmed, DP Dearnaley, MA Hawkins, ... The lancet oncology 14 (1), e28-e37, 2013 | 551 | 2013 |
| The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20 TJ Postma, NK Aaronson, JJ Heimans, MJ Muller, JG Hildebrand, ... European journal of cancer 41 (8), 1135-1139, 2005 | 532 | 2005 |
| Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial DP Dearnaley, G Jovic, I Syndikus, V Khoo, RA Cowan, JD Graham, ... The lancet oncology 15 (4), 464-473, 2014 | 528 | 2014 |
| Identification of seven new prostate cancer susceptibility loci through a genome-wide association study RA Eeles, Z Kote-Jarai, AA Al Olama, GG Giles, M Guy, G Severi, K Muir, ... Nature genetics 41 (10), 1116-1121, 2009 | 487 | 2009 |
| Testicular germ-cell cancer A Horwich, J Shipley, R Huddart The Lancet 367 (9512), 754-765, 2006 | 480 | 2006 |
| Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas M Cullen, N Steven, L Billingham, C Gaunt, M Hastings, P Simmonds, ... New England Journal of Medicine 353 (10), 988-998, 2005 | 469 | 2005 |
| Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System) V Panebianco, Y Narumi, E Altun, BH Bochner, JA Efstathiou, S Hafeez, ... European urology 74 (3), 294-306, 2018 | 460 | 2018 |
| Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours JM O’sullivan, RA Huddart, AR Norman, J Nicholls, DP Dearnaley, ... Annals of Oncology 14 (1), 91-96, 2003 | 419 | 2003 |
| Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ... The Lancet Oncology 22 (7), 931-945, 2021 | 397 | 2021 |
| Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer C Turnbull, EA Rapley, S Seal, D Pernet, A Renwick, D Hughes, ... Nature genetics 42 (7), 604-607, 2010 | 369 | 2010 |
| Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial D Dearnaley, I Syndikus, G Sumo, M Bidmead, D Bloomfield, C Clark, ... The lancet oncology 13 (1), 43-54, 2012 | 366 | 2012 |
| Prostate cancer patients' support and psychological care needs: survey from a non‐surgical oncology clinic K Lintz, C Moynihan, S Steginga, A Norman, R Eeles, R Huddart, ... Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2003 | 364 | 2003 |
